- Cardiovascular
- Contraception
- Pain Management / Neurological Disorders
- Smoking Cessation
- Others
Transdermal Drug Delivery Systems Market size was valued at USD 53,721.5 million in 2023, growing at a CAGR of 5.1% from 2024-2030. Transdermal Drug Delivery Systems Market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It's a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations.
The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the transdermal drug delivery systems market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.
Transdermal Drug Delivery Systems Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.1%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Transdermal Drug Delivery Systems Market Dynamics
An increase in the global population has significantly increased the demand for geriatric medicines. Also, transdermal drug delivery systems help deliver drugs in a controlled manner, thereby increasing the effectiveness of geriatric medicines. Apart from this, the number of patients suffering from chronic diseases, such as heart disease, diabetes, and arthritis has steadily increased these days, and also these chronic diseases are a leading cause of disability and death globally. Additionally, rising awareness among patients, regarding the use of enormous medicines has also increased. These factors have impacted positively the global transdermal drug delivery systems market growth.
Asia Pacific Got Significant Share
Transdermal Drug Delivery Systems Market Regional Analysis
Asia Pacific is expected to emerge as the largest revenue-generating region in the globe transdermal drug delivery market due to the growing patient population suffering from chronic diseases and rising awareness about disease management in both developed and developing countries such as China and India.
Latin America
Europe
Asia Pacific
Middle East
North America
Transdermal Drug Delivery Systems Market Segmentation
By Application
By Technology
- Electric Current
- Electroporation
- Radio Frequency
- Thermal
- Ultrasound
- Others
Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.
The major factors driving the market growth are the increases in the demand for self-administration of drugs for the long-term treatment of diverse disorders.
Business expansion is a key growth strategy opted by industry players of transdermal drug delivery system.
Key Features of the Reports
- The transdermal drug delivery market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
| 1. Executive Summary |
| 2. Global Transdermal Drug Delivery Systems Market Introduction |
| 2.1.Global Transdermal Drug Delivery Systems Market - Taxonomy |
| 2.2.Global Transdermal Drug Delivery Systems Market - Definitions |
| 2.2.1.Application |
| 2.2.2.Technology |
| 2.2.3.Region |
| 3. Global Transdermal Drug Delivery Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Transdermal Drug Delivery Systems Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Transdermal Drug Delivery Systems Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Cardiovascular |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Contraception |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Pain Management / Neurological Disorders |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Smoking Cessation |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Transdermal Drug Delivery Systems Market By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Electric Current |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Electroporation |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Radio Frequency |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Thermal |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Ultrasound |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Transdermal Drug Delivery Systems Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Transdermal Drug Delivery Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Cardiovascular |
| 8.1.2.Contraception |
| 8.1.3.Pain Management / Neurological Disorders |
| 8.1.4.Smoking Cessation |
| 8.1.5.Others |
| 8.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Electric Current |
| 8.2.2.Electroporation |
| 8.2.3.Radio Frequency |
| 8.2.4.Thermal |
| 8.2.5.Ultrasound |
| 8.2.6.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Transdermal Drug Delivery Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cardiovascular |
| 9.1.2.Contraception |
| 9.1.3.Pain Management / Neurological Disorders |
| 9.1.4.Smoking Cessation |
| 9.1.5.Others |
| 9.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Electric Current |
| 9.2.2.Electroporation |
| 9.2.3.Radio Frequency |
| 9.2.4.Thermal |
| 9.2.5.Ultrasound |
| 9.2.6.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Transdermal Drug Delivery Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cardiovascular |
| 10.1.2.Contraception |
| 10.1.3.Pain Management / Neurological Disorders |
| 10.1.4.Smoking Cessation |
| 10.1.5.Others |
| 10.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Electric Current |
| 10.2.2.Electroporation |
| 10.2.3.Radio Frequency |
| 10.2.4.Thermal |
| 10.2.5.Ultrasound |
| 10.2.6.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Transdermal Drug Delivery Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cardiovascular |
| 11.1.2.Contraception |
| 11.1.3.Pain Management / Neurological Disorders |
| 11.1.4.Smoking Cessation |
| 11.1.5.Others |
| 11.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Electric Current |
| 11.2.2.Electroporation |
| 11.2.3.Radio Frequency |
| 11.2.4.Thermal |
| 11.2.5.Ultrasound |
| 11.2.6.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Transdermal Drug Delivery Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cardiovascular |
| 12.1.2.Contraception |
| 12.1.3.Pain Management / Neurological Disorders |
| 12.1.4.Smoking Cessation |
| 12.1.5.Others |
| 12.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Electric Current |
| 12.2.2.Electroporation |
| 12.2.3.Radio Frequency |
| 12.2.4.Thermal |
| 12.2.5.Ultrasound |
| 12.2.6.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1. Novartis AG (Switzerland) |
| 13.2.2. Boehringer Ingelheim GmbH (Germany) |
| 13.2.3. Generex Biotechnology Corp. (Canada) |
| 13.2.4. Echo Therapeutics, Inc. (U.S.) |
| 13.2.5. Crescita Therapeutics Inc (Canada) |
| 13.2.6. MedPharm (U.K.) |
| 13.2.7. Pantec Biosolutions AG (Liechtenstein) |
| 13.2.8. Transdermal Corp. (U.S.) |
| 13.2.9. Noven Pharmaceuticals, Inc. (U.S.) |
| 13.2.10. Actelion Pharmaceuticals Ltd (Switzerland) |
| 13.2.11. Johnson & Johnson Limited (U.S.) |
| 13.2.12. 3M Pharmaceuticals Inc. (U.S.) |
| 13.2.13. Mylan Pharmaceuticals Inc. (U.S.) |
| 13.2.14. GlaxoSmithKline plc (U.K.) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Novartis AG (Switzerland)
- Boehringer Ingelheim GmbH (Germany)
- Generex Biotechnology Corp. (Canada)
- Echo Therapeutics, Inc. (U.S.)
- Crescita Therapeutics Inc (Canada)
- MedPharm (U.K.)
- Pantec Biosolutions AG (Liechtenstein)
- Transdermal Corp. (U.S.)
- Noven Pharmaceuticals, Inc. (U.S.)
- Actelion Pharmaceuticals Ltd (Switzerland)
- Johnson & Johnson Limited (U.S.)
- 3M Pharmaceuticals Inc. (U.S.)
- Mylan Pharmaceuticals Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)